RESIDUAL GASTRIC VOLUME IN MORBIDLY OBESE DIABETICS AFTER AN OVERNIGHT FASTING OR 3 HOURS OF A CARBOHYDRATE-ENRICHED SUPPLEMENT: A RANDOMIZED CROSSOVER PILOT STUDY.

What Was Tested

The paper reports a study of Copper (Supplement), published as a randomized controlled trial.

The aim of this study was to assess the RGV in morbidly obese diabetic patients after traditional or abbreviated fasting.

Why It Was Studied

Prolonged preoperative fasting presents some adverse consequences and has been abandoned for most surgical procedures, except for obese and/or diabetic patients.

Who Took Part

By PubMed's age tags, the people studied were adults.

This is a prospective, randomized, and crossover design study in eight morbidly obese type II diabetic patients.

How the Study Was Run

In design terms this was a randomized, crossover and pilot study.

The participants were allocated by chance, so the Copper (Supplement) group and the comparison group should start out alike.

In the crossover set-up each of the participants took both Copper (Supplement) and the comparison in turn, acting as their own control.

It is described as a pilot, a small early test of whether a larger Copper (Supplement) study would be practical.

This study was approved by the Ethics Committee for Research with Human Beings from the Federal University of Mato Grosso, under number 179.017/2012.

What Was Measured

Topics PubMed links to this paper include Pilot Projects, Diabetes Mellitus, Type 2, Obesity, Morbid, Gastric Emptying, Fasting and Carbohydrates.

What This Means in Plain Language

The paper is a randomized, crossover and pilot study of Copper (Supplement).

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2024 (Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery), a journal based in Brazil.

More context: the Copper (Supplement) compound page, all human trials.